Skip to main
BFRA
BFRA logo

Biofrontera (BFRA)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Biofrontera (BFRA) Stock

About Biofrontera (BFRA)

Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.
Market cap$70.33M
Today's volume
Revenue (TTM)$19.67M
Avg. daily volume1.66K
EBITDA (TTM)-$4.34M
Open
Price / earnings ratio5.41x
Today's range
Debt / equity4.85x
52 week range$1.5 - $6.89
5 year debt / equity195.92x
Beta (LTM)1.03x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio2.04x
Ex-dividend date
Next earningsAug 18, 2022
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 09, 2025, the market cap for BFRA stock is $70.33M

The current P/E ratio for BFRA stock is 5.41

The 52-week high for BFRA stock is $6.89. The current BFRA stock price $undefined is 100.00% below its 52-week high

The 52-week low for BFRA stock is $1.50. The current BFRA stock price $undefined has increased 100.00% from its 52-week low

No, the BFRA stock does not pay dividends to its shareholders

How to buy BFRA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in BFRA stock

    Navigate to the Explore page. Then, type BFRA into the search bar. When you see BFRA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased BFRA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Biofrontera Stock Earnings

The value each BFRA share was expected to gain vs. the value that each BFRA share actually gained.

Biofrontera (BFRA) reported Q4 2021 earnings per share (EPS) of $2.15, beating estimates of -$0.14 by 1,635.71%. In the same quarter last year, Biofrontera's earnings per share (EPS) was $0. Biofrontera is expected to release next earnings on 08/18/2022, with an earnings per share (EPS) estimate of $0.

Buy Biofrontera (BFRA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.